66 related articles for article (PubMed ID: 3930757)
1. Disruption of the blood-brain barrier in hyperammonemic coma and the pharmacologic effects of dexamethasone and difluoromethyl ornithine.
Sears ES; McCandless DW; Chandler MD
J Neurosci Res; 1985; 14(2):255-61. PubMed ID: 3930757
[TBL] [Abstract][Full Text] [Related]
2. Changes in the permeability of the blood-brain barrier in acute hyperammonemia. Effect of dexamethasone.
Ziylan YZ; Uzüm G; Bernard G; Diler AS; Bourre JM
Mol Chem Neuropathol; 1993 Dec; 20(3):203-18. PubMed ID: 8172625
[TBL] [Abstract][Full Text] [Related]
3. Brain methanethiol and ammonia concentrations in experimental hepatic coma and coma induced by injections of various combinations of these substances.
Zieve L; Doizaki WM; Lyftogt C
J Lab Clin Med; 1984 Nov; 104(5):655-64. PubMed ID: 6491466
[TBL] [Abstract][Full Text] [Related]
4. Enhanced endogenous ornithine concentrations protect against tonic seizures and coma in acute ammonia intoxication.
Seiler N; Sarhan S; Knoedgen B; Hornsperger JM; Sablone M
Pharmacol Toxicol; 1993 Feb; 72(2):116-23. PubMed ID: 8097310
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat.
Therrien G; Rose C; Butterworth J; Butterworth RF
Hepatology; 1997 Mar; 25(3):551-6. PubMed ID: 9049197
[TBL] [Abstract][Full Text] [Related]
6. Difluoromethylornithine decreases postischemic brain edema and blood-brain barrier breakdown.
Schmitz MP; Combs DJ; Dempsey RJ
Neurosurgery; 1993 Nov; 33(5):882-7; discussion 887-8. PubMed ID: 8264888
[TBL] [Abstract][Full Text] [Related]
7. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
Heston WD; Fleischmann J; Tackett RE; Ratliff TL
Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
[TBL] [Abstract][Full Text] [Related]
8. Fulminant hyperammonaemia induced by thiopental coma in rats.
Ivnitsky JJ; Rejniuk VL; Schäfer TV; Malakhovsky VN
Toxicology; 2006 Jul; 224(3):184-90. PubMed ID: 16704891
[TBL] [Abstract][Full Text] [Related]
9. Impaired development of central and peripheral catecholamine neurotransmitter systems in preweanling rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase.
Slotkin TA; Grignolo A; Whitmore WL; Lerea L; Trepanier PA; Barnes GA; Weigel SJ; Seidler FJ; Bartolome J
J Pharmacol Exp Ther; 1982 Sep; 222(3):746-51. PubMed ID: 6125588
[TBL] [Abstract][Full Text] [Related]
10. The relationship between erythropoietin pretreatment with blood-brain barrier and lipid peroxidation after ischemia/reperfusion in rats.
Bahcekapili N; Uzüm G; Gökkusu C; Kuru A; Ziylan YZ
Life Sci; 2007 Mar; 80(14):1245-51. PubMed ID: 17300815
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
12. Hyperammonemic coma after hepatectomy in germ-free rats.
Schalm SW; van der Mey T
Gastroenterology; 1979 Aug; 77(2):231-4. PubMed ID: 447036
[TBL] [Abstract][Full Text] [Related]
13. Control of nucleic acid and protein synthesis in developing brain, kidney, and heart of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
Slotkin TA; Persons D; Slepetis RJ; Taylor D; Bartolome J
Teratology; 1984 Oct; 30(2):211-24. PubMed ID: 6208628
[TBL] [Abstract][Full Text] [Related]
14. Acute administration of 3,4-methylenedioxymethamphetamine induces profound hyperthermia, blood-brain barrier disruption, brain edema formation, and cell injury.
Sharma HS; Ali SF
Ann N Y Acad Sci; 2008 Oct; 1139():242-58. PubMed ID: 18991870
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
16. Antitumor properties of (2R,5R)-6-heptyne-2,5-diamine, a new potent enzyme-activated irreversible inhibitor of ornithine decarboxylase, in rodents.
Bartholeyns J; Mamont P; Casara P
Cancer Res; 1984 Nov; 44(11):4972-7. PubMed ID: 6435861
[TBL] [Abstract][Full Text] [Related]
17. Effects of acute exposure to aluminum on blood-brain barrier and the protection of zinc.
Song Y; Xue Y; Liu X; Wang P; Liu L
Neurosci Lett; 2008 Nov; 445(1):42-6. PubMed ID: 18786610
[TBL] [Abstract][Full Text] [Related]
18. Failure of L-carnitine to protect mice against hyperammonemia induced by ammonium acetate or urease injection.
Deshmukh DR; Singh KR; Meert K; Deshmukh GD
Pediatr Res; 1990 Sep; 28(3):256-60. PubMed ID: 2235123
[TBL] [Abstract][Full Text] [Related]
19. Effect of ethanol, chlorpromazine and dexamethasone on blood-brain barrier dysfunction to albumin around large cerebral stab wounds.
Rosengren LE; Persson LI
Cytobios; 1981; 31(122):81-90. PubMed ID: 7198570
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ornithine decarboxylase with 2-difluoromethylornithine: reduced incidence of dimethylhydrazine-induced colon tumors in mice.
Kingsnorth AN; King WW; Diekema KA; McCann PP; Ross JS; Malt RA
Cancer Res; 1983 Jun; 43(6):2545-9. PubMed ID: 6406047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
